To evaluate the therapeutic effect of PDGFRA inhibition on tumor growth in vivo, we administered Cre (15 mg/kg) or 5% glycerol formal (Gly, solvent) to an orthotopic murine model of GL261 glioma for 7 days. The gene discussed is PDGFRA; the disease is central nervous system cancer.